Cardiff Oncology, Inc. - COM (CRDF)

Historical Portfolio Holders from Q2 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
8.26 M
Holdings value Q1 2024
$44.1 M
Value change Q1 2024
+$16.4 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
72
Number of buys Q1 2024
41
Number of sells Q1 2024
-15
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
14147L108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 8.26 M $44.1 M +$16.4 M $5.34 72
2023 Q4 5.26 M $7.79 M -$209 K $1.48 52
2023 Q3 5.42 M $7.54 M -$761 K $1.39 55
2023 Q2 5.96 M $8.76 M -$1.4 M $1.47 48
2023 Q1 7.03 M $11.6 M -$750 K $1.65 50
2022 Q4 7.68 M $10.8 M -$321 K $1.40 53
2022 Q3 7.92 M $12.2 M -$1.96 M $1.54 48
2022 Q2 7.86 M $17.3 M -$14.1 M $2.20 50
2022 Q1 13.8 M $34.2 M -$29.2 M $2.48 78
2021 Q4 21.4 M $128 M +$2.41 M $6.01 78
2021 Q3 21 M $140 M -$33.6 M $6.66 83
2021 Q2 26.4 M $175 M +$10.1 M $6.65 83
2021 Q1 24.1 M $223 M -$73.1 M $9.26 71
2020 Q4 25.7 M $462 M +$144 M $17.99 77
2020 Q3 18.7 M $265 M +$208 M $14.19 64
2020 Q2 4.92 M $24.7 M +$24.7 M $5.01 22